Role of phospholipase D in the activation of protein kinase D by lysophosphatidic acid

2004 ◽  
Vol 315 (1) ◽  
pp. 139-143 ◽  
Author(s):  
Yoonseok Kam ◽  
John H Exton
Keyword(s):  
Protein Kinase ◽  
Phospholipase D ◽  
Lysophosphatidic Acid ◽  
Protein Kinase D

scholarly journals Targeting of Protein Kinase C-ϵ during Fcγ Receptor-dependent Phagocytosis Requires the ϵC1B Domain and Phospholipase C-γ1

2006 ◽  
Vol 17 (2) ◽  
pp. 799-813 ◽  
Author(s):  
Keylon L. Cheeseman ◽  
Takehiko Ueyama ◽  
Tanya M. Michaud ◽  
Kaori Kashiwagi ◽  
Demin Wang ◽  
...  
Keyword(s):  
Protein Kinase C ◽  
Protein Kinase ◽  
Phospholipase C ◽  
Phospholipase D ◽  
Fluorescent Protein ◽  
Wild Type ◽  
Fcγ Receptor ◽  
Kinase C ◽  
Green Fluorescent

Protein kinase C-ϵ (PKC-ϵ) translocates to phagosomes and promotes uptake of IgG-opsonized targets. To identify the regions responsible for this concentration, green fluorescent protein (GFP)-protein kinase C-ϵ mutants were tracked during phagocytosis and in response to exogenous lipids. Deletion of the diacylglycerol (DAG)-binding ϵC1 and ϵC1B domains, or the ϵC1B point mutant ϵC259G, decreased accumulation at phagosomes and membrane translocation in response to exogenous DAG. Quantitation of GFP revealed that ϵC259G, ϵC1, and ϵC1B accumulation at phagosomes was significantly less than that of intact PKC-ϵ. Also, the DAG antagonist 1-hexadecyl-2-acetyl glycerol (EI-150) blocked PKC-ϵ translocation. Thus, DAG binding to ϵC1B is necessary for PKC-ϵ translocation. The role of phospholipase D (PLD), phosphatidylinositol-specific phospholipase C (PI-PLC)-γ1, and PI-PLC-γ2 in PKC-ϵ accumulation was assessed. Although GFP-PLD2 localized to phagosomes and enhanced phagocytosis, PLD inhibition did not alter target ingestion or PKC-ϵ localization. In contrast, the PI-PLC inhibitor U73122 decreased both phagocytosis and PKC-ϵ accumulation. Although expression of PI-PLC-γ2 is higher than that of PI-PLC-γ1, PI-PLC-γ1 but not PI-PLC-γ2 consistently concentrated at phagosomes. Macrophages from PI-PLC-γ2-/-mice were similar to wild-type macrophages in their rate and extent of phagocytosis, their accumulation of PKC-ϵ at the phagosome, and their sensitivity to U73122. This implicates PI-PLC-γ1 as the enzyme that supports PKC-ϵ localization and phagocytosis. That PI-PLC-γ1 was transiently tyrosine phosphorylated in nascent phagosomes is consistent with this conclusion. Together, these results support a model in which PI-PLC-γ1 provides DAG that binds to ϵC1B, facilitating PKC-ϵ localization to phagosomes for efficient IgG-mediated phagocytosis.

scholarly journals A role for phospholipase D in angiotensin II-induced protein kinase D activation in adrenal glomerulosa cell models

2013 ◽  
Vol 366 (1) ◽  
pp. 31-37 ◽  
Author(s):  
Lawrence O. Olala ◽  
Mutsa Seremwe ◽  
Ying-Ying Tsai ◽  
Wendy B. Bollag
Keyword(s):  
Angiotensin Ii ◽  
Protein Kinase ◽  
Phospholipase D ◽  
Protein Kinase D ◽  
Cell Models

scholarly journals Cooperation of Gq, Gi, and G12/13in Protein Kinase D Activation and Phosphorylation Induced by Lysophosphatidic Acid

2002 ◽  
Vol 278 (7) ◽  
pp. 4882-4891 ◽  
Author(s):  
Jingzhen Yuan ◽  
Lee W. Slice ◽  
Jennifer Gu ◽  
Enrique Rozengurt
Keyword(s):  
Protein Kinase ◽  
Lysophosphatidic Acid ◽  
Protein Kinase D

scholarly journals Critical role of protein kinase D in VEGF‐induced vascular permeability and angiogenesis

2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
Zheng Gen Jin ◽  
Jinjing Zhao ◽  
Meimei Yin ◽  
Il‐Sun Kwon ◽  
Michael Mastrangelo
Keyword(s):  
Protein Kinase ◽  
Vascular Permeability ◽  
Critical Role ◽  
Protein Kinase D

Impaired insulin exocytosis in chronic hepatitis C infection: contributory role of p38δ MAPK–protein kinase D–golgi complex axis

2020 ◽  
Vol 134 (12) ◽  
pp. 1449-1456
Author(s):  
Parimala Narne
Keyword(s):  
Hepatitis C ◽  
Protein Kinase ◽  
Golgi Complex ◽  
Hcv Infection ◽  
Protein Kinase D ◽  
Cell Dysfunction ◽  
Chronic Hcv Infection ◽  
Chronic Hcv ◽  
Insulin Exocytosis

Abstract Hepatitis C virus (HCV) infection and chronic hepatitis C (CHC) are associated with a measurable risk of insulin resistance (IR)/impaired glucose tolerance (IGT)/diabetes mellitus (DM). While loss of hepatic endocrine function contributes to liver cirrhosis in diabetic patients, onset and progression of IR/IGT to diabetes and exacerbation of incident hyperglycemia are ostensibly linked with chronic HCV infection. In this regard, the study by Chen J et al. appearing in Clinical Science (2020) (134(5) https://doi.org/10.1042/CS20190900) attempts to understand the mechanisms underlying the savaging effects of chronic HCV infection on insulin-producing pancreatic β-cells and hence diabetic onset. The study investigated the role of mitogen-activated protein kinase (MAPK) p38δ–protein kinase D (PKD)–golgi complex axis in impacting insulin exocytosis. It was inferred that an insulin secretory defect of pancreatic β-cells, owing to disrupted insulin exocytosis, to an extent explains β-cell dysfunction in HCV-infected or CHC milieu. HCV infection negatively regulates first-phase and second-phase insulin secretion by impinging on PKD-dependent insulin secretory granule fission at trans-golgi network and insulin secretory vesicle membrane fusion events. This commentary highlights the study in question, that deciphered the contribution of p38δ MAPK–PKD–golgi complex axis to β-cell dysfunction in CHC milieu. This pivotal axis proffers a formidable therapeutic opportunity for alleviation of double burden of glucose abnormalities/DM and CHC.

Sign in / Sign up

Export Citation Format

Share Document